Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARREST trial of adjunctive rifampicin for Staphylococcus aureus bacteraemia
2012-000344-10Phase 4Completed
- Sponsor
- Medical Research Council
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rifampicin in Staphylococcal bacteremia (2 arms), sponsored by Medical Research Council. Primary endpoints: All-cause mortality through 14 days from randomisation and Bacteriological failure or death. Started May 2012; status: completed.
02
Drugs
rifampicin
03
Conditions
Staphylococcal bacteremia
Beyond the preview
Go deeper on 2012-000344-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000344-10.